ArticleClinical kidney journal2021

Control of hyperparathyroidism with the intravenous calcimimetic etelcalcetide in dialysis patients adherent and non-adherent to oral calcimimetics.

Maria Dolores Arenas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.